Lassogen Company

Lassogen is a biotechnology company exploring lasso peptides as a way to develop new medicines. Lassogen was founded in 2019 to unlock the full potential of lasso peptides as a new therapeutic modality for diagnosing and treating some of our most intractable health challenges. The company is the result of a convergence of technological advances that have opened the door to a vast, new, untapped source of novel medicines.
Industry: Early Drug Development
Headquarters: San Diego, California, United States
Founded Date: 2019-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 4
Total Funding: 4500000
Estimated Revenue: Less than $1M
Last Funding Date: 2020-10-13
Last Funding Type: Seed

Visit Website
Register and Claim Ownership